{"organizations": [], "uuid": "bb19c6f7a9bacc35f2abd32f7dd63c869c6966d8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/apricus-fda/fda-asks-for-new-formulation-of-apricus-erectile-dysfunction-cream-idUSL3N1RT48H", "country": "US", "domain_rank": 408, "title": "FDA asks for new formulation of Apricus' erectile dysfunction cream", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-16T14:06:00.000+03:00", "replies_count": 0, "uuid": "bb19c6f7a9bacc35f2abd32f7dd63c869c6966d8"}, "author": "", "url": "https://www.reuters.com/article/apricus-fda/fda-asks-for-new-formulation-of-apricus-erectile-dysfunction-cream-idUSL3N1RT48H", "ord_in_thread": 0, "title": "FDA asks for new formulation of Apricus' erectile dysfunction cream", "locations": [], "entities": {"persons": [{"name": "anil d’silva", "sentiment": "none"}, {"name": "tamara mathias", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "min read    drugmaker apricus biosciences inc", "sentiment": "none"}, {"name": "u.s. food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 16 (Reuters) - Drugmaker Apricus Biosciences Inc said on Monday the U.S. regulator directed it to develop a new formulation for its erectile dysfunction cream, Vitaros, which was rejected in February.\nThe U.S. Food And Drug Administration also confirmed that two new late-stage studies would need to be conducted to test the reformulated product. (Reporting by Tamara Mathias in Bengaluru; Editing by Anil D’Silva)\n ", "external_links": [], "published": "2018-04-16T14:06:00.000+03:00", "crawled": "2018-04-16T14:28:14.020+03:00", "highlightTitle": ""}